Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through...

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Left ventricular (LV) remodeling after acute myocardial infarction (MI) leads to heart failure.
• Pre-infarction treatment with granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) can attenuate LV remodeling.
• The efficacy of initiating G-CSF and SCF treatment after MI remains to be fully elucidated.

Purpose of the Study:

• To investigate the therapeutic potential of initiating cytokine treatment after acute myocardial infarction.
• To determine if G-CSF and SCF administration post-MI can prevent left ventricular remodeling and dysfunction.
• To explore the underlying mechanisms, including neovascularization and apoptosis, of post-MI cytokine therapy.

Main Methods:

• Acute myocardial infarction (MI) was induced in mice.
• Bone marrow transplantation from enhanced green fluorescent protein (GFP)-expressing mice was performed.
• Mice were assigned to five treatment groups: saline, pre-MI G-CSF/SCF, post-MI G-CSF/SCF, post-MI G-CSF alone, and post-MI SCF alone.
• Left ventricular remodeling, cardiac function, survival rates, capillary density (GFP+ cells), and apoptosis were assessed.

Main Results:

• All treatment groups receiving G-CSF after MI demonstrated reduced LV remodeling and improved cardiac function.
• Survival rates were significantly higher in G-CSF treated groups compared to controls.
• G-CSF treatment led to increased capillary formation and decreased apoptosis in the infarct border zone.
• SCF alone did not show significant beneficial effects.

Conclusions:

• Cytokine therapy initiated after acute myocardial infarction can effectively prevent left ventricular remodeling and dysfunction.
• Granulocyte colony-stimulating factor (G-CSF) plays a crucial role in mediating these beneficial effects.
• The therapeutic benefits are associated with enhanced neovascularization and reduced cellular apoptosis in the cardiac border area.